Articles

Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma

Sarah Cannon Research Institute, Nashville, TN;Tennessee Oncology PLLC, Nashville, TN
Sarah Cannon Research Institute, Nashville, TN;Florida Cancer Specialists, Ft Myers, FL
Sarah Cannon Research Institute, Nashville, TN;Florida Cancer Specialists, Ft Myers, FL
Sarah Cannon Research Institute, Nashville, TN;Tennessee Oncology PLLC, Nashville, TN
Oncology Hematology Care, Cincinnati, OH
Woodlands Medical Specialists, Pensacola, FL, USA
Sarah Cannon Research Institute, Nashville, TN;Tennessee Oncology PLLC, Nashville, TN
Sarah Cannon Research Institute, Nashville, TN;Tennessee Oncology PLLC, Nashville, TN
Vol. 100 No. 5 (2015): May, 2015 https://doi.org/10.3324/haematol.2014.119735